Related Experiment Video
Updated: May 7, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
The pathophysiological relationship and clinical significance of left atrial function and left ventricular diastolic
Anna G Kostopoulou1, Dimitrios P Tsiapras, Antigoni S Chaidaroglou
1Department of Cardiology, Onassis Cardiac Surgery Center, Athens, Greece.
Insights
Cardiac dysfunction in beta-thalassemia major begins with early atrial mechanical depression, preceding left ventricular issues. This finding aids in identifying cardiac damage and arrhythmias in affected patients.
Area of Science:
- Cardiology
- Hematology
- Pathophysiology
Background:
- Beta-thalassemia major involves iron deposition, inflammation, and immunogenetics, contributing to cardiac dysfunction.
- Early detection of cardiac involvement is crucial for managing beta-thalassemia major patients.
Purpose of the Study:
- To investigate early signs of cardiac dysfunction in beta-thalassemia major by examining left atrial and ventricular mechanical and endocrine function.
- To compare cardiac function in patients with beta-thalassemia and healthy controls.
Main Methods:
- Echocardiography and natriuretic peptide measurements (NT-proBNP, proANP) were performed on 90 patients and 90 controls.
- 24-hour Holter monitoring was used to assess arrhythmia prevalence.
- Analysis focused on left atrial and ventricular function indices, including the E/E' ratio.
Main Results:
- Atrial function was impaired early in beta-thalassemia patients, preceding left ventricular diastolic and systolic dysfunction.
- The E/E' ratio increased with age, indicating diastolic dysfunction by the third decade in patients.
- Elevated natriuretic peptides and a 26% incidence of atrial fibrillation were observed in patients.
Conclusions:
- Atrial mechanical depression is an early echocardiographic indicator of cardiac damage in beta-thalassemia major.
- This early dysfunction precedes detectable left ventricular issues and is linked to supraventricular arrhythmias.
Abstract:
Iron deposition in combination with inflammatory and immunogenetic factors is involved in the pathophysiology of cardiac dysfunction in β-thalassemia major. We investigated the mechanical and endocrine function of the left atrium and ventricle to identify early signs of dysfunction. We studied 90 patients (mean age: 29 ± 11 years) with β-thalassemia and normal left ventricular function and 90 age and sex-matched healthy controls. Patients and controls underwent a thorough cardiac echocardiographic study and measurements of the b-type (NT-proBNP) and atrial natriuretic peptides (proANP). Patients underwent 24-hr Holter recordings for arrhythmia monitoring. In the patient group, atria were affected early during the course of the disease, prior to diastolic and systolic left ventricular dysfunction. The E/E'ratio (E Doppler mitral fast inflow to the corresponding tissue Doppler E) continually increased with age (P < 0.05) and reached levels indicating left ventricular diastolic dysfunction (E/E' > 15) in the third decade whereas indexes of active and passive atrial function decreased gradually throughout life. In controls, the E/E' ratio continually increased with age but with later (fifth decade) appearance of diastolic dysfunction and a compensatory increase in atrial active function. Both natriuretic peptides were significantly increased in patients compared to controls (558 ± 141 and 2,580 ± 1,830 fmol/mL for NT-proBNP and proANP versus 332 ± 106 and 1,331 ± 1,134 fmol/mL, respectively). Atrial fibrillation was found in a subgroup of 23 (26%) patients, older in age with mild diastolic function and enlarged, depressed atria. In conclusion, atrial mechanical depression seems to be a very early sign of cardiac damage. It may become echocardiographically evident even before diastolic and systolic dysfunction and is associated to supraventricular arrhythmias.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis I: Introduction
Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Mitral Valve Prolapse I: Introduction
Heart Failure II: Pathophysiology

